Miscarriage after a normal scan at 12-14 gestational weeks in women at low risk of carrying a fetus with chromosomal anomaly according to nuchal translucency screening

Ultrasound in Obstetrics and Gynecology

Volumn 30, Issue 5, 2007, Pages 728-736

  Westin, M ^a,b   Kallen K ^c   Saltvedt, S ^d   Almstrom H ^e   Grunewald, C ^d   Valentin, L ^a,b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF LUND   (Sweden)

^d STOCKHOLM SÖDER HOSPITAL   (Sweden)

^e DANDERYD HOSPITAL   (Sweden)

Author keywords

Mid trimester; Risk factors; Spontaneous miscarriage; Ultrasonography

Indexed keywords

ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; DEMOGRAPHY; DOWN SYNDROME; FETUS; FETUS KARYOTYPING; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PARITY; PRIORITY JOURNAL; RISK ASSESSMENT; SPONTANEOUS ABORTION;

ABORTION, SPONTANEOUS; ADULT; CHROMOSOME ABERRATIONS; DOWN SYNDROME; FEMALE; HUMANS; KARYOTYPING; MASS SCREENING; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; RISK ASSESSMENT; RISK FACTORS;

EID: 35348936607     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.5138     Document Type: Article

References (55)

1. Pandya PP, Snijders RJ, Johnson SP, De Lourdes Brizot M, Nicolaides KH. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 1995; 102: 957-962.
2. Taipale P, Hiilesmaa V, Salonen R, Ylostalo P. Increased nuchal translucency as a marker for fetal chromosomal defects. N Engl J Med 1997; 337: 1654-1658.
3. Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Lancet 1998; 352: 343-346.
4. Reynders CS, Pauker SP, Benacerraf BR. First trimester isolated fetal nuchal lucency: significance and outcome. J Ultrasound Med 1997; 16: 101-105.
5. Bilardo CM, Pajkrt E, de Graaf I, Mol BW, Bleker OP. Outcome of fetuses with enlarged nuchal translucency and normal karyotype. Ultrasound Obstet Gynecol 1998; 11: 401-406.
6. Souka AP, Snijders RJ, Novakov A, Soares W, Nicolaides KH. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 1998; 11: 391-400.
7. van Vugt JM, Tinnemans BW, van Zalen-Sprock RM. Outcome and early childhood follow-up of chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks' gestation. Ultrasound Obstet Gynecol 1998; 11: 407-409.
8. Adekunle O, Gopee A, el-Sayed M, Thilaganathan B. Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population. Br J Radiol 1999; 72: 457-460.
9. Pajkrt E, Mol BW, Bleker OP, Bilardo CM. Pregnancy outcome and nuchal translucency measurements in fetuses with a normal karyotype. Prenat Diagn 1999; 19: 1104-1108.
10. Mangione R, Guyon F, Taine L, Wen ZQ, Roux D, Vergnaud A, Maugey-Laulom B, Horovitz J, Saura R. Pregnancy outcome and prognosis in fetuses with increased first-trimester nuchal translucency. Fetal Diagn Ther 2001; 16: 360-363.
11. Michailidis GD, Economides DL. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses. Ultrasound Obstet Gynecol 2001; 17: 102-105.
12. Souka AP, Krampl E, Bakalis S, Heath V, Nicolaides KH. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 2001; 18: 9-17.
13. Cheng CC, Bahado-Singh RO, Chen SC, Tsai MS. Pregnancy outcomes with increased nuchal translucency after routine Down syndrome screening. Int J Gynaecol Obstet 2004; 84: 5-9.
14. Saltvedt S, Almstrom H, Kublickas M, Valentin L, Bottinga R, Bui TH, Cederholm M, Conner P, Dannberg B, Malcus P, Marsk A, Grunewald C. Screening for Down syndrome based on maternal age or fetal nuchal translucency: a randomized controlled trial in 39 572 pregnancies. Ultrasound Obstet Gynecol 2005; 25: 537-545.
15. Saltvedt S, Almstrom H, Kublickas M, Valentin L, Grunewald C. Detection of malformations in chromosomally normal fetuses by routine ultrasound at 12 or 18 weeks of gestation - a randomised controlled trial in 39,572 pregnancies. BJOG 2006; 113: 664-674.
16. Westin M, Saltvedt S, Bergman G, Kublickas M, Almstrom H, Grunewald C, Valentin L. Routine ultrasound examination at 12 or 18 gestational weeks for prenatal detection of major congenital heart malformations? A randomised controlled trial comprising 36,229 fetuses. BJOG 2006; 113: 675-682.
17. Nicolaides KH, Sebire NJ, Snijders R. The 11-14 Week Scan. Parthenon: London, 1999.
18. Westin M, Saltvedt S, Almström H, Grunewald C, Valentin L. By how much does increased nuchal translucency increase the risk of adverse pregnancy outcome in chromosomally normal foetuses? A study in 16 260 foetuses derived from an unselected pregnant population. Ultrasound Obstet Gynecol 2007; 29: 150-158.
19. Selbing A, Kjessler B. Conceptual dating by ultrasonic measurement of the fetal biparietal diameter in early pregnancy. Acta Obstet Gynecol Scand 1985; 64: 593-597.
20. Selbing A, Fjällbrant B. Accuracy of conceptual age estimation from fetal crown-rump length. J Clin Ultrasound 1984; 12: 343-346.
21. Hosmer DW, Lemeshow S. Applied Logistic Regression. Wiley: New York, 1989.
22. Anderson JC, Smith A, Trent RJ, Boogert A, Ellwood DA. Outcome of 1500 consecutive chorionic villus samplings. Med J Aust 1991; 155: 657-661.
23. Tabor A, Philip J, Madsen M, Bang J, Obel EB, Norgaard-Pedersen B. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1986; 1: 1287-1293.
24. Kuliev A, Jackson L, Froster U, Brambati B, Simpson JL, Verlinsky Y, Ginsberg N, Smidt-Jensen S, Zakut H. Chorionic villus sampling safety. Report of World Health Organization/EURO meeting in association with the Seventh International Conference on Early Prenatal Diagnosis of Genetic Diseases, Tel-Aviv, Israel, 21 May 1994. Am J Obstet Gynecol 1996; 174: 807-811.
25. Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004; 191: 45-67.
26. Smith KE, Buyalos RP. The profound impact of patient age on pregnancy outcome after early detection of fetal cardiac activity. Fertil Steril 1996; 65: 35-40.
27. Makrydimas G, Sebire NJ, Lolis D, Vlassis N, Nicolaides KH. Fetal loss following ultrasound diagnosis of a live fetus at 6-10 weeks of gestation. Ultrasound Obstet Gynecol 2003; 22: 368-372.
28. Benson CB, Doubilet PM, Cooney MJ, Frates MC, David V, Hornstein MD. Early singleton pregnancy outcome: effects of maternal age and mode of conception. Radiology 1997; 203: 399-403.
29. Mackenzie WE, Holmes DS, Newton JR. Spontaneous abortion rate in ultrasonographically viable pregnancies. Obstet Gynecol 1988; 71: 81-83.
30. Hoesli IM, Walter-Göbel I, Tercanli S, Holzgreve W. Spontaneous fetal loss rates in a non-selected population. Am J Med Genet 2001; 100: 106-109.
31. Naylor AF, Warburton D. Sequential analysis of spontaneous abortion. II. Collaborative study data show that gravidity determines a very substantial rise in risk. Fertil Steril 1979; 31: 282-286.
32. Risch HA, Weiss NS, Clarke EA, Miller AB. Risk factors for spontaneous abortion and its recurrence. Am J Epidemiol 1988; 128: 420-430.
33. Parazzini F, Chatenoud L, Tozzi L, Benzi G, DalPino D, Fedele L. Determinants of risk of spontaneous abortions in the first trimester of pregnancy. Epidemiology 1997; 8: 681-683.
34. Buss L, Tolstrup J, Munk C, Bergholt T, Ottesen B, Granbaek M, Kjaer SK. Spontaneous abortion: a prospective cohort study of younger women from the general population in Denmark. Validation, occurrence and risk determinants. Acta Obstet Gynecol Scand 2006; 85: 467-475.
35. Ancel PY, Saurel-Cubizolles MJ, Di Renzo GC, Papiernik E, Bréart G. Risk factors for 14-21 week abortions: a case-control study in Europe. The Europop Group. Hum Reprod 2000; 15: 2426-2432.
36. Yang CJ, Stone P, Stewart AW. The epidemiology of recurrent miscarriage: a descriptive study of 1214 pregnant women with recurrent miscarriage. Aust N Z J Obstet Gynaecol 2006; 46: 316-322.
37. Lashen H, Fear K, Sturdee DW. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod 2004; 19: 1644-1646.
38. Nielsen A, Hannibal CG, Lindekilde BE, Tolstrup J, Frederiksen K, Munk C, Bergholt T, Buss L, Ottesen B, Gronbaek M, Kjaer SK. Maternal smoking predicts the risk of spontaneous abortion. Acta Obstet Gynecol Scand 2006; 85: 1057-1065.
39. Crane JP, Wahl N. The role of maternal diabetes in repetitive spontaneous abortion. Fertil Steril 1981; 36: 477-479.
40. Chamley LW. Antiphospholipid antibodies or not? The role of beta 2 glycoprotein 1 in autoantibody-mediated pregnancy loss. J Reprod Immunol 1997; 36: 123-142 [review].
41. Poulose T, Richardson R, Ewings P, Fox R. Probability of early pregnancy loss in women with vaginal bleeding and a singleton live fetus at ultrasound scan. J Obstet Gynaecol 2006; 26: 782-784.
42. Jauniaux E, Hempstock J, Greenwold N, Burton GJ. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol 2003; 162: 115-125.
43. Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ 2000; 320: 1708-1712.
44. George L, Granath F, Johansson AL, Olander B, Cnattingius S. Risks of repeated miscarriage. Paediatr Perinat Epidemiol 2006; 20: 119-126.
45. Hook EB, Cross PK, Regal RR. The frequency of 47, +21, 47, +18, and 47, +3 at the uppermost extremes of maternal ages: results on 56,094 fetuses studied prenatally and comparisons with data on livebirths. Hum Genet 1984; 68: 211-220.
46. Ferguson-Smith MA, Yates JR. Maternal age specific rates for chromosome aberrations and factors influencing them: report of a collaborative european study on 52 965 amniocenteses. Prenat Diagn 1984; 4: 5-44.
47. Trokoudes KM, Skordis N, Picolos MK. Infertility and thyroid disorder. Curr Opin Obstet Gynecol 2006; 18: 446-451.
48. Stewart EA. Uterine fibroids. Lancet 2001; 27: 293-298.
49. Olausson PO, Cnattingius S, Haglund B. Teenage pregnancies and risk of late fetal death and infant mortality. Br J Obstet Gynaecol 1999; 106: 116-121.
50. Magadi M. Poor pregnancy outcomes among adolescents in South Nyanza region of Kenya. Afr J Reprod Health 2006; 10: 26-38.
51. Makinson C. The health consequences of teenage fertility. Fam Plann Perspect 1985; 17: 132-139.
52. Scholl TO, Hediger ML, Huang J, Johnson FE, Smith W, Ances IG. Young maternal age and parity. Influences on pregnancy outcome. Ann Epidemiol 1992; 2: 565-575.
53. Hediger ML, Scholl TO, Schall JI, Krueger PM. Young maternal age and preterm labor. Ann Epidemiol 1997; 7: 400-406.
54. Hook EB, Cross PK, Schreinemachers DM. Chromosomal abnormality rates at amniocentesis and in live-born infants. JAMA 1983; 249: 2034-2038.
55. Hook EB, Lindsjo A. Down syndrome in live births by single year maternal age interval in a Swedish study: comparison with results from a New York State study. Am J Hum Genet 1978; 30: 19-27.